메뉴 건너뛰기




Volumn 38, Issue 6, 2007, Pages 704-713

Biological options to enhance periprosthetic bone mass

Author keywords

Bisphosphonate; Bone; Fracture; Mass; Parathyroid hormone; Periprosthetic

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; DOXYCYCLINE; ESTROGEN; ETANERCEPT; GROWTH HORMONE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; OSTEOPROTEGERIN; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PARVOVIRUS VECTOR; RALOXIFENE; RECOMBINANT PARATHYROID HORMONE; RECOMBINANT SOMATOMEDIN C; RISEDRONIC ACID; SALCATONIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOMATOMEDIN C; STRONTIUM RANELATE; TIBOLONE; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; VITAMIN D;

EID: 34248151930     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2007.02.051     Document Type: Article
Times cited : (24)

References (141)
  • 1
    • 0030787629 scopus 로고    scopus 로고
    • Periprosthetic bone remodelling after cementless total hip replacement. A prospective comparison of two different implant designs
    • Ang K.C., Das De S., Goh J.C., et al. Periprosthetic bone remodelling after cementless total hip replacement. A prospective comparison of two different implant designs. J Bone Joint Surg Br 79 (1997) 675-679
    • (1997) J Bone Joint Surg Br , vol.79 , pp. 675-679
    • Ang, K.C.1    Das De, S.2    Goh, J.C.3
  • 2
    • 31544450709 scopus 로고    scopus 로고
    • Changes of the biochemical markers of bone turnover and periprosthetic bone remodeling after cemented hip arthroplasty
    • Arabmotlagh M., Sabljic R., and Rittmeister M. Changes of the biochemical markers of bone turnover and periprosthetic bone remodeling after cemented hip arthroplasty. J Arthroplast 21 (2006) 129-134
    • (2006) J Arthroplast , vol.21 , pp. 129-134
    • Arabmotlagh, M.1    Sabljic, R.2    Rittmeister, M.3
  • 3
    • 33746123524 scopus 로고    scopus 로고
    • Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study
    • Arabmotlagh M., Rittmeister M., and Hennigs T. Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: prospective randomized double-blind study. J Orthop Res 24 (2006) 1336-1341
    • (2006) J Orthop Res , vol.24 , pp. 1336-1341
    • Arabmotlagh, M.1    Rittmeister, M.2    Hennigs, T.3
  • 4
    • 0041331740 scopus 로고    scopus 로고
    • Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal
    • Bagger Y.Z., Tanko L.B., Alexandersen P., et al. Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal. Bone 33 (2003) 301-307
    • (2003) Bone , vol.33 , pp. 301-307
    • Bagger, Y.Z.1    Tanko, L.B.2    Alexandersen, P.3
  • 5
    • 0034961499 scopus 로고    scopus 로고
    • Tibolone and its effects on bone: a review
    • Berning B., Bennink H.J., and Fauser B.C. Tibolone and its effects on bone: a review. Climacteric 4 (2001) 120-136
    • (2001) Climacteric , vol.4 , pp. 120-136
    • Berning, B.1    Bennink, H.J.2    Fauser, B.C.3
  • 6
    • 0012953649 scopus 로고    scopus 로고
    • Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study
    • Berning B., Kuijk C.V., Kuiper J.W., et al. Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study. Bone 19 (1996) 395-399
    • (1996) Bone , vol.19 , pp. 395-399
    • Berning, B.1    Kuijk, C.V.2    Kuiper, J.W.3
  • 7
    • 13444252253 scopus 로고    scopus 로고
    • Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis
    • Bhandari M., Bajammal S., Guyatt G.H., et al. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J Bone Joint Surg Am 87 (2005) 293-301
    • (2005) J Bone Joint Surg Am , vol.87 , pp. 293-301
    • Bhandari, M.1    Bajammal, S.2    Guyatt, G.H.3
  • 8
    • 23444452077 scopus 로고    scopus 로고
    • One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis
    • Black D.M., Bilezikian J.P., Ensrud K.E., et al. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med 353 (2005) 555-565
    • (2005) N Engl J Med , vol.353 , pp. 555-565
    • Black, D.M.1    Bilezikian, J.P.2    Ensrud, K.E.3
  • 9
    • 0004851872 scopus 로고    scopus 로고
    • Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
    • Black D.M., Cummings S.R., Karpf D.B., et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348 (1996) 1535-1541
    • (1996) Lancet , vol.348 , pp. 1535-1541
    • Black, D.M.1    Cummings, S.R.2    Karpf, D.B.3
  • 10
    • 0141684971 scopus 로고    scopus 로고
    • The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis
    • Black D.M., Greenspan S.L., Ensrud K.E., et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349 (2003) 1207-1215
    • (2003) N Engl J Med , vol.349 , pp. 1207-1215
    • Black, D.M.1    Greenspan, S.L.2    Ensrud, K.E.3
  • 11
    • 0026519501 scopus 로고
    • Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty
    • Bobyn J.D., Mortimer E.S., Glassman A.H., et al. Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty. Clin Orthop Relat Res 274 (1992) 79-96
    • (1992) Clin Orthop Relat Res , vol.274 , pp. 79-96
    • Bobyn, J.D.1    Mortimer, E.S.2    Glassman, A.H.3
  • 12
    • 18644374464 scopus 로고    scopus 로고
    • A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis
    • Body J.J., Gaich G.A., Scheele W.H., et al. A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87 (2002) 4528-4535
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 4528-4535
    • Body, J.J.1    Gaich, G.A.2    Scheele, W.H.3
  • 13
    • 0036241632 scopus 로고    scopus 로고
    • Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis
    • Body J.J. Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis. Bone 30 (2002) 75S-79S
    • (2002) Bone , vol.30
    • Body, J.J.1
  • 15
    • 0028822698 scopus 로고
    • Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study
    • Brixen K., Kassem M., Nielsen H.K., et al. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study. J Bone Miner Res 10 (1995) 1865-1874
    • (1995) J Bone Miner Res , vol.10 , pp. 1865-1874
    • Brixen, K.1    Kassem, M.2    Nielsen, H.K.3
  • 16
    • 0141499869 scopus 로고    scopus 로고
    • Is the calcium receptor a molecular target for the actions of strontium on bone?
    • Brown E.M. Is the calcium receptor a molecular target for the actions of strontium on bone?. Osteoporos Int 14 (2003) S25-S34
    • (2003) Osteoporos Int , vol.14
    • Brown, E.M.1
  • 17
    • 0019132265 scopus 로고
    • Stimulation of DNA and collagen synthesis by autologous growth factor in cultured fetal rat calvaria
    • Canalis E., Peck W.A., and Raisz L.G. Stimulation of DNA and collagen synthesis by autologous growth factor in cultured fetal rat calvaria. Science 210 (1980) 1021-1023
    • (1980) Science , vol.210 , pp. 1021-1023
    • Canalis, E.1    Peck, W.A.2    Raisz, L.G.3
  • 18
    • 0036093132 scopus 로고    scopus 로고
    • Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles
    • Carmody E.E., Schwarz E.M., Puzas J.E., Rosier R.N., and O'Keefe R.J. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis Rheum 46 (2002) 1298-1308
    • (2002) Arthritis Rheum , vol.46 , pp. 1298-1308
    • Carmody, E.E.1    Schwarz, E.M.2    Puzas, J.E.3    Rosier, R.N.4    O'Keefe, R.J.5
  • 19
    • 0035120523 scopus 로고    scopus 로고
    • Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation
    • Cauley J.A., Norton L., Lippman M.E., et al. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat 65 (2001) 125-134
    • (2001) Breast Cancer Res Treat , vol.65 , pp. 125-134
    • Cauley, J.A.1    Norton, L.2    Lippman, M.E.3
  • 20
    • 0141705375 scopus 로고    scopus 로고
    • Effects of oestrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial
    • Cauley J.A., Robbins J., Chen Z., et al. Effects of oestrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 290 (2003) 1729-1738
    • (2003) JAMA , vol.290 , pp. 1729-1738
    • Cauley, J.A.1    Robbins, J.2    Chen, Z.3
  • 21
    • 0033829969 scopus 로고    scopus 로고
    • A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group
    • Chesnut III C.H., Silverman S., Andriano K., et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med 109 (2000) 267-276
    • (2000) Am J Med , vol.109 , pp. 267-276
    • Chesnut III, C.H.1    Silverman, S.2    Andriano, K.3
  • 23
    • 0035214153 scopus 로고    scopus 로고
    • Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis
    • Childs L.M., Goater J.J., O'Keefe R.J., and Schwarz E.M. Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am 83-A (2001) 1789-1797
    • (2001) J Bone Joint Surg Am , vol.83 -A , pp. 1789-1797
    • Childs, L.M.1    Goater, J.J.2    O'Keefe, R.J.3    Schwarz, E.M.4
  • 24
    • 33750517302 scopus 로고    scopus 로고
    • Anabolic therapy for osteoporosis: parathyroid hormone
    • Cosman F. Anabolic therapy for osteoporosis: parathyroid hormone. Curr Rheumatol Rep 8 (2006) 63-69
    • (2006) Curr Rheumatol Rep , vol.8 , pp. 63-69
    • Cosman, F.1
  • 25
    • 0033575083 scopus 로고    scopus 로고
    • The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation
    • Cummings S.R., Eckert S., Krueger K.A., et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 281 (1999) 2189-2197
    • (1999) JAMA , vol.281 , pp. 2189-2197
    • Cummings, S.R.1    Eckert, S.2    Krueger, K.A.3
  • 26
    • 28544442824 scopus 로고    scopus 로고
    • Bone microarchitecture evaluated by histomorphometry
    • Dalle Carbonare L., Valenti M.T., Bertoldo F., et al. Bone microarchitecture evaluated by histomorphometry. Micron 36 (2005) 609-616
    • (2005) Micron , vol.36 , pp. 609-616
    • Dalle Carbonare, L.1    Valenti, M.T.2    Bertoldo, F.3
  • 27
    • 0025134899 scopus 로고
    • A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women
    • Dawson-Hughes B., Dallal G.E., Krall E.A., et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323 (1990) 878-883
    • (1990) N Engl J Med , vol.323 , pp. 878-883
    • Dawson-Hughes, B.1    Dallal, G.E.2    Krall, E.A.3
  • 28
    • 0030763532 scopus 로고    scopus 로고
    • Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
    • Dawson-Hughes B., Harris S.S., Krall E.A., and Dallal G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337 (1997) 670-676
    • (1997) N Engl J Med , vol.337 , pp. 670-676
    • Dawson-Hughes, B.1    Harris, S.S.2    Krall, E.A.3    Dallal, G.E.4
  • 29
    • 0037042498 scopus 로고    scopus 로고
    • Treatment of postmenopausal osteoporosis
    • Delmas P.D. Treatment of postmenopausal osteoporosis. Lancet 359 (2002) 2018-2026
    • (2002) Lancet , vol.359 , pp. 2018-2026
    • Delmas, P.D.1
  • 30
    • 18544381541 scopus 로고    scopus 로고
    • Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial
    • Delmas P.D., Ensrud K.E., Adachi J.D., et al. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab 87 (2002) 3609-3617
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 3609-3617
    • Delmas, P.D.1    Ensrud, K.E.2    Adachi, J.D.3
  • 31
    • 9044249713 scopus 로고    scopus 로고
    • Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis
    • Devogelaer J.P., Broll H., Correa-Rotter R., et al. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone 18 (1996) 141-150
    • (1996) Bone , vol.18 , pp. 141-150
    • Devogelaer, J.P.1    Broll, H.2    Correa-Rotter, R.3
  • 32
    • 27744607999 scopus 로고    scopus 로고
    • Current concepts of molecular aspects of bone healing
    • Dimitriou R., Tsiridis E., and Giannoudis P.V. Current concepts of molecular aspects of bone healing. Injury 36 (2005) 1392-1404
    • (2005) Injury , vol.36 , pp. 1392-1404
    • Dimitriou, R.1    Tsiridis, E.2    Giannoudis, P.V.3
  • 33
    • 33846392691 scopus 로고    scopus 로고
    • In vitro evaluation of the direct effect of estradiol on human osteoblasts (HOB) and human mesenchymal stem cells (h-MSCs)
    • Disilvio L., Jameson J., Gamie Z., et al. In vitro evaluation of the direct effect of estradiol on human osteoblasts (HOB) and human mesenchymal stem cells (h-MSCs). Injury 37 (2006) S33-S42
    • (2006) Injury , vol.37
    • Disilvio, L.1    Jameson, J.2    Gamie, Z.3
  • 35
    • 0033581212 scopus 로고    scopus 로고
    • Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
    • Ettinger B., Black D.M., Mitlak B.H., et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282 (1999) 637-645
    • (1999) JAMA , vol.282 , pp. 637-645
    • Ettinger, B.1    Black, D.M.2    Mitlak, B.H.3
  • 36
    • 0141796739 scopus 로고    scopus 로고
    • The effects of parathyroid hormone, alendronate, or both in men with osteoporosis
    • Finkelstein J.S., Hayes A., Hunzelman J.L., et al. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349 (2003) 1216-1226
    • (2003) N Engl J Med , vol.349 , pp. 1216-1226
    • Finkelstein, J.S.1    Hayes, A.2    Hunzelman, J.L.3
  • 37
    • 0014684354 scopus 로고
    • Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo
    • Fleisch H., Russell R.G., and Francis M.D. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science 165 (1969) 1262-1264
    • (1969) Science , vol.165 , pp. 1262-1264
    • Fleisch, H.1    Russell, R.G.2    Francis, M.D.3
  • 38
    • 33645099604 scopus 로고    scopus 로고
    • Combination of anabolic and antiresorptive agents for the treatment of osteoporosis
    • Garces C., and Garcia L.E. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis. Maturitas 54 (2006) 47-54
    • (2006) Maturitas , vol.54 , pp. 47-54
    • Garces, C.1    Garcia, L.E.2
  • 39
    • 0028866912 scopus 로고
    • Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women
    • Ghiron L.J., Thompson J.L., Holloway L., et al. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. J Bone Miner Res 10 (1995) 1844-1852
    • (1995) J Bone Miner Res , vol.10 , pp. 1844-1852
    • Ghiron, L.J.1    Thompson, J.L.2    Holloway, L.3
  • 41
    • 33845983304 scopus 로고    scopus 로고
    • The use of parathyroid hormone in the treatment of osteoporosis
    • Girotra M., Rubin M.R., and Bilezikian JP. The use of parathyroid hormone in the treatment of osteoporosis. Rev Endocr Metab Disord 7 (2006) 113-121
    • (2006) Rev Endocr Metab Disord , vol.7 , pp. 113-121
    • Girotra, M.1    Rubin, M.R.2    Bilezikian JP3
  • 42
    • 0031979896 scopus 로고    scopus 로고
    • Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo
    • Giuliani N., Pedrazzoni M., Negri G., et al. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 22 (1998) 455-461
    • (1998) Bone , vol.22 , pp. 455-461
    • Giuliani, N.1    Pedrazzoni, M.2    Negri, G.3
  • 43
    • 0036124068 scopus 로고    scopus 로고
    • Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis
    • Goater J.J., O'Keefe R.J., Rosier R.N., et al. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 20 (2002) 169-173
    • (2002) J Orthop Res , vol.20 , pp. 169-173
    • Goater, J.J.1    O'Keefe, R.J.2    Rosier, R.N.3
  • 44
    • 0032975067 scopus 로고    scopus 로고
    • Early postmenopausal bone loss is prevented by oestrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of oestrogen and/or 1alpha-OH-vitamin D3
    • Gorai I., Chaki O., Taguchi Y., et al. Early postmenopausal bone loss is prevented by oestrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of oestrogen and/or 1alpha-OH-vitamin D3. Calcif Tissue Int 65 (1999) 16-22
    • (1999) Calcif Tissue Int , vol.65 , pp. 16-22
    • Gorai, I.1    Chaki, O.2    Taguchi, Y.3
  • 45
    • 0029799208 scopus 로고    scopus 로고
    • Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa
    • Grinspoon S., Baum H., Lee K., et al. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 81 (1996) 3864-3870
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 3864-3870
    • Grinspoon, S.1    Baum, H.2    Lee, K.3
  • 46
    • 0018687995 scopus 로고
    • Modes of failure of cemented stem-type femoral components: a radiographic analysis of loosening
    • Gruen T.A., McNeice G.M., and Amstutz H.C. Modes of failure of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res 141 (1979) 17-27
    • (1979) Clin Orthop Relat Res , vol.141 , pp. 17-27
    • Gruen, T.A.1    McNeice, G.M.2    Amstutz, H.C.3
  • 47
    • 0031440180 scopus 로고    scopus 로고
    • The Dall-Miles cable and plate system for periprosthetic femoral fractures
    • Haddad F.S., Marston R.A., and Muirhead-Allwood S.K. The Dall-Miles cable and plate system for periprosthetic femoral fractures. Injury 28 (1997) 445-447
    • (1997) Injury , vol.28 , pp. 445-447
    • Haddad, F.S.1    Marston, R.A.2    Muirhead-Allwood, S.K.3
  • 48
    • 0035662497 scopus 로고    scopus 로고
    • Fresh frozen bone in femoral impaction grafting: can developments in bone regeneration improve on this?
    • Heliotis M., and Tsiridis E.E. Fresh frozen bone in femoral impaction grafting: can developments in bone regeneration improve on this?. Med Hypotheses 57 (2001) 675-678
    • (2001) Med Hypotheses , vol.57 , pp. 675-678
    • Heliotis, M.1    Tsiridis, E.E.2
  • 49
    • 0036184843 scopus 로고    scopus 로고
    • Dose-dependent prevention of early periprosthetic bone loss by alendronate
    • German
    • Hennigs T., Arabmotlagh M., Schwarz A., and Zichner L. Dose-dependent prevention of early periprosthetic bone loss by alendronate. Z Orthop Ihre Grenzgeb 140 (2002) 42-47 German
    • (2002) Z Orthop Ihre Grenzgeb , vol.140 , pp. 42-47
    • Hennigs, T.1    Arabmotlagh, M.2    Schwarz, A.3    Zichner, L.4
  • 50
    • 21344454577 scopus 로고    scopus 로고
    • Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use
    • Hodsman A.B., Bauer D.C., Dempster D.W., et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 26 (2005) 688-703
    • (2005) Endocr Rev , vol.26 , pp. 688-703
    • Hodsman, A.B.1    Bauer, D.C.2    Dempster, D.W.3
  • 51
    • 0028146277 scopus 로고
    • Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women
    • Holloway L., Butterfield G., Hintz R.L., et al. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 79 (1994) 470-479
    • (1994) J Clin Endocrinol Metab , vol.79 , pp. 470-479
    • Holloway, L.1    Butterfield, G.2    Hintz, R.L.3
  • 52
    • 0025642527 scopus 로고
    • The various stress patterns of press-fit, ingrown, and cemented femoral stems
    • Huiskes R. The various stress patterns of press-fit, ingrown, and cemented femoral stems. Clin Orthop Relat Res 261 (1990) 27-38
    • (1990) Clin Orthop Relat Res , vol.261 , pp. 27-38
    • Huiskes, R.1
  • 53
    • 0026604141 scopus 로고
    • The relationship between stress shielding and bone resorption around total hip stems and the effects of flexible materials
    • Huiskes R., Weinans H., and van Rietbergen B. The relationship between stress shielding and bone resorption around total hip stems and the effects of flexible materials. Clin Orthop Relat Res 274 (1992) 124-134
    • (1992) Clin Orthop Relat Res , vol.274 , pp. 124-134
    • Huiskes, R.1    Weinans, H.2    van Rietbergen, B.3
  • 54
    • 0034925511 scopus 로고    scopus 로고
    • Apoptosis in interface membranes of aseptically loose total hip arthroplasty
    • Huk O.L., Zukor D.J., Ralston W., et al. Apoptosis in interface membranes of aseptically loose total hip arthroplasty. J Mater Sci Mater Med 12 (2001) 653-658
    • (2001) J Mater Sci Mater Med , vol.12 , pp. 653-658
    • Huk, O.L.1    Zukor, D.J.2    Ralston, W.3
  • 55
    • 0037795672 scopus 로고    scopus 로고
    • Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture
    • Huusko T.M., Karppi P., Kautiainen H., et al. Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture. Calcif Tissue Int 71 (2002) 478-484
    • (2002) Calcif Tissue Int , vol.71 , pp. 478-484
    • Huusko, T.M.1    Karppi, P.2    Kautiainen, H.3
  • 56
    • 1642306206 scopus 로고    scopus 로고
    • Osteoblast proliferation and maturation by bisphosphonates
    • Im G.I., Qureshi S.A., Kenney J., et al. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 25 (2004) 4105-4115
    • (2004) Biomaterials , vol.25 , pp. 4105-4115
    • Im, G.I.1    Qureshi, S.A.2    Kenney, J.3
  • 57
    • 32644467389 scopus 로고    scopus 로고
    • Calcium plus vitamin D supplementation and the risk of fractures
    • Jackson R.D., LaCroix A.Z., Gass M., et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354 (2006) 669-683
    • (2006) N Engl J Med , vol.354 , pp. 669-683
    • Jackson, R.D.1    LaCroix, A.Z.2    Gass, M.3
  • 59
    • 0242413030 scopus 로고    scopus 로고
    • Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure
    • Jang Y., Zhao J.J., Mitlak B.H., et al. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18 (2003) 1932-1941
    • (2003) J Bone Miner Res , vol.18 , pp. 1932-1941
    • Jang, Y.1    Zhao, J.J.2    Mitlak, B.H.3
  • 60
    • 0028500510 scopus 로고
    • Fit of the uncemented femoral component and the use of cement influence the strain transfer the femoral cortex
    • Jasty M., O'Connor D.O., Henshaw R.M., et al. Fit of the uncemented femoral component and the use of cement influence the strain transfer the femoral cortex. J Orthop Res 12 (1994) 648-656
    • (1994) J Orthop Res , vol.12 , pp. 648-656
    • Jasty, M.1    O'Connor, D.O.2    Henshaw, R.M.3
  • 61
    • 0033029332 scopus 로고    scopus 로고
    • The Mennen plate: unsuitable for elderly femoral peri-prosthetic fractures
    • Kamineni S., and Ware H.E. The Mennen plate: unsuitable for elderly femoral peri-prosthetic fractures. Injury 30 (1999) 257-260
    • (1999) Injury , vol.30 , pp. 257-260
    • Kamineni, S.1    Ware, H.E.2
  • 62
    • 20944432461 scopus 로고    scopus 로고
    • Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study
    • Kaskani E., Lyritis G.P., Kosmidis C., et al. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study. Clin Rheumatol 24 3 (2005) 232-238
    • (2005) Clin Rheumatol , vol.24 , Issue.3 , pp. 232-238
    • Kaskani, E.1    Lyritis, G.P.2    Kosmidis, C.3
  • 63
    • 33644887196 scopus 로고    scopus 로고
    • Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study
    • Kinov P., Tivchev P., Doukova P., and Leithner A. Effect of risedronate on bone metabolism after total hip arthroplasty: a prospective randomised study. Acta Orthop Belg 72 (2006) 44-50
    • (2006) Acta Orthop Belg , vol.72 , pp. 44-50
    • Kinov, P.1    Tivchev, P.2    Doukova, P.3    Leithner, A.4
  • 64
    • 1642289532 scopus 로고    scopus 로고
    • Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice
    • Kostenuik P.J., Bolon B., Morony S., et al. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. Bone 34 (2004) 656-664
    • (2004) Bone , vol.34 , pp. 656-664
    • Kostenuik, P.J.1    Bolon, B.2    Morony, S.3
  • 65
    • 0029758076 scopus 로고    scopus 로고
    • Evaluation of periprosthetic bone using dual-energy X-ray absorptiometry: precision of the method and effect of operation on bone mineral density
    • Kroger H., Miettinen H., Arnala I., et al. Evaluation of periprosthetic bone using dual-energy X-ray absorptiometry: precision of the method and effect of operation on bone mineral density. J Bone Miner Res 11 (1996) 1526-1530
    • (1996) J Bone Miner Res , vol.11 , pp. 1526-1530
    • Kroger, H.1    Miettinen, H.2    Arnala, I.3
  • 66
    • 0037370988 scopus 로고    scopus 로고
    • Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial
    • Landin-Wilhelmsen K., Nilsson A., Bosaeus I., and Bengtsson B.A. Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized placebo-controlled trial. J Bone Miner Res 18 (2003) 393-405
    • (2003) J Bone Miner Res , vol.18 , pp. 393-405
    • Landin-Wilhelmsen, K.1    Nilsson, A.2    Bosaeus, I.3    Bengtsson, B.A.4
  • 67
    • 0034054290 scopus 로고    scopus 로고
    • Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial
    • Lane N.E., Sanchez S., Modin G.W., et al. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial. J Bone Miner Res 15 (2000) 944-951
    • (2000) J Bone Miner Res , vol.15 , pp. 944-951
    • Lane, N.E.1    Sanchez, S.2    Modin, G.W.3
  • 68
    • 0032452531 scopus 로고    scopus 로고
    • Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study
    • Langlois J.A., Rosen C.J., Visser M., et al. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab 83 (1998) 4257-4262
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 4257-4262
    • Langlois, J.A.1    Rosen, C.J.2    Visser, M.3
  • 69
    • 33644846297 scopus 로고    scopus 로고
    • Review of guidelines for bone mineral density testing and treatment of osteoporosis
    • Lewiecki E.M. Review of guidelines for bone mineral density testing and treatment of osteoporosis. Curr Osteoporos Rep 3 (2005) 75-83
    • (2005) Curr Osteoporos Rep , vol.3 , pp. 75-83
    • Lewiecki, E.M.1
  • 70
    • 34248195278 scopus 로고    scopus 로고
    • Is alendronate therapy cost-effective for postmenopausal osteopenia?
    • Lewiecki E.M. Is alendronate therapy cost-effective for postmenopausal osteopenia?. Nat Clin Pract Endocrinol Metab 1 (2005) 74-75
    • (2005) Nat Clin Pract Endocrinol Metab , vol.1 , pp. 74-75
    • Lewiecki, E.M.1
  • 71
    • 33751235565 scopus 로고    scopus 로고
    • Redefining osteoporosis treatment: who to treat and how long to treat
    • Lewiecki E.M., and Silverman S.L. Redefining osteoporosis treatment: who to treat and how long to treat. Arq Bras Endocrinol Metabol 50 (2006) 694-704
    • (2006) Arq Bras Endocrinol Metabol , vol.50 , pp. 694-704
    • Lewiecki, E.M.1    Silverman, S.L.2
  • 72
    • 0034815044 scopus 로고    scopus 로고
    • Mechanisms of action and therapeutic potential of strontium in bone
    • Marie P.J., Ammann P., Boivin G., and Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 69 (2001) 121-129
    • (2001) Calcif Tissue Int , vol.69 , pp. 121-129
    • Marie, P.J.1    Ammann, P.2    Boivin, G.3    Rey, C.4
  • 73
    • 9144233479 scopus 로고    scopus 로고
    • The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
    • Meunier P.J., Roux C., Seeman E., et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350 (2004) 459-468
    • (2004) N Engl J Med , vol.350 , pp. 459-468
    • Meunier, P.J.1    Roux, C.2    Seeman, E.3
  • 74
    • 18344379873 scopus 로고    scopus 로고
    • Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis-a 2-year randomized placebo controlled trial
    • Meunier P.J., Slosman D.O., Delmas P.D., et al. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis-a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 87 (2002) 2060-2066
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 2060-2066
    • Meunier, P.J.1    Slosman, D.O.2    Delmas, P.D.3
  • 75
    • 0036481537 scopus 로고    scopus 로고
    • Effects of alendronate on particle-induced osteolysis in a rat model
    • Millett P.J., Allen M.J., and Bostrom M.P. Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am 84-A (2002) 236-249
    • (2002) J Bone Joint Surg Am , vol.84 -A , pp. 236-249
    • Millett, P.J.1    Allen, M.J.2    Bostrom, M.P.3
  • 76
    • 29244470458 scopus 로고    scopus 로고
    • Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1alpha-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone loss
    • Mizunuma H., Shiraki M., Shintani M., et al. Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1alpha-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone loss. J Bone Miner Metab 24 (2006) 11-15
    • (2006) J Bone Miner Metab , vol.24 , pp. 11-15
    • Mizunuma, H.1    Shiraki, M.2    Shintani, M.3
  • 77
    • 21444449689 scopus 로고    scopus 로고
    • Bisphosphonates in orthopaedic surgery
    • Morris C.D., and Einhorn T.A. Bisphosphonates in orthopaedic surgery. J Bone Joint Surg Am 87 (2005) 1609-1618
    • (2005) J Bone Joint Surg Am , vol.87 , pp. 1609-1618
    • Morris, C.D.1    Einhorn, T.A.2
  • 78
    • 15544388054 scopus 로고    scopus 로고
    • Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur
    • Nagashima M., Sakai A., Uchida S., et al. Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur. Bone 36 (2005) 502-511
    • (2005) Bone , vol.36 , pp. 502-511
    • Nagashima, M.1    Sakai, A.2    Uchida, S.3
  • 79
    • 0033861352 scopus 로고    scopus 로고
    • Human bone-derived cells support formation of human osteoclasts from arthroplasty-derived cells in vitro
    • Neale S.D., Fujikawa Y., Sabokbar A., et al. Human bone-derived cells support formation of human osteoclasts from arthroplasty-derived cells in vitro. J Bone Joint Surg Br 82 (2000) 892-900
    • (2000) J Bone Joint Surg Br , vol.82 , pp. 892-900
    • Neale, S.D.1    Fujikawa, Y.2    Sabokbar, A.3
  • 80
    • 0033855980 scopus 로고    scopus 로고
    • The effect of particle phagocytosis and metallic wear particles on osteoclast formation and bone resorption in vitro
    • Neale S.D., Haynes D.R., Howie D.W., et al. The effect of particle phagocytosis and metallic wear particles on osteoclast formation and bone resorption in vitro. J Arthroplasty 15 (2000) 654-662
    • (2000) J Arthroplasty , vol.15 , pp. 654-662
    • Neale, S.D.1    Haynes, D.R.2    Howie, D.W.3
  • 81
    • 0033197881 scopus 로고    scopus 로고
    • Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption
    • Neale S.D., Sabokbar A., Howie D.W., et al. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption. J Orthop Res 17 (1999) 686-694
    • (1999) J Orthop Res , vol.17 , pp. 686-694
    • Neale, S.D.1    Sabokbar, A.2    Howie, D.W.3
  • 82
    • 0035837553 scopus 로고    scopus 로고
    • Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
    • Neer R.M., Arnaud C.D., Zanchetta J.R., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344 (2001) 1434-1441
    • (2001) N Engl J Med , vol.344 , pp. 1434-1441
    • Neer, R.M.1    Arnaud, C.D.2    Zanchetta, J.R.3
  • 83
    • 0345528123 scopus 로고    scopus 로고
    • Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study
    • French
    • Nehme A., Maalouf G., Tricoire J.L., et al. Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study. Rev Chir Orthop Reparatrice Appar Mot 89 (2003) 593-598 French
    • (2003) Rev Chir Orthop Reparatrice Appar Mot , vol.89 , pp. 593-598
    • Nehme, A.1    Maalouf, G.2    Tricoire, J.L.3
  • 84
    • 27144464518 scopus 로고    scopus 로고
    • The insulin-like growth factor-I gene and osteoporosis: a critical appraisal
    • Niu T., and Rosen C.J. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 361 (2005) 38-56
    • (2005) Gene , vol.361 , pp. 38-56
    • Niu, T.1    Rosen, C.J.2
  • 85
    • 31544476254 scopus 로고    scopus 로고
    • Predictions on preserving bone mass in knee arthroplasty with bisphosphonates
    • Nyman J.S., Rodrigo J.J., Hazelwood S.J., et al. Predictions on preserving bone mass in knee arthroplasty with bisphosphonates. J Arthroplasty 21 (2006) 106-113
    • (2006) J Arthroplasty , vol.21 , pp. 106-113
    • Nyman, J.S.1    Rodrigo, J.J.2    Hazelwood, S.J.3
  • 86
    • 0037396421 scopus 로고    scopus 로고
    • Doxycycline inhibits bone resorption by human interface membrane cells from aseptically loose hip replacements
    • Ong S.M., and Taylor G.J. Doxycycline inhibits bone resorption by human interface membrane cells from aseptically loose hip replacements. J Bone Joint Surg Br 85 (2003) 456-461
    • (2003) J Bone Joint Surg Br , vol.85 , pp. 456-461
    • Ong, S.M.1    Taylor, G.J.2
  • 87
    • 28744448698 scopus 로고    scopus 로고
    • Sclerostin and Wnt signaling-the pathway to bone strength
    • Ott S.M. Sclerostin and Wnt signaling-the pathway to bone strength. J Clin Endocrinol Metab 90 (2005) 6741-6743
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 6741-6743
    • Ott, S.M.1
  • 88
    • 0030018531 scopus 로고    scopus 로고
    • A new biochemical marker of bone resorption for follow-up on treatment with nasal salmon calcitonin
    • Overgaard K., and Christiansen C. A new biochemical marker of bone resorption for follow-up on treatment with nasal salmon calcitonin. Calcif Tissue Int 59 (1996) 12-16
    • (1996) Calcif Tissue Int , vol.59 , pp. 12-16
    • Overgaard, K.1    Christiansen, C.2
  • 89
    • 0028067130 scopus 로고
    • Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: a dose-response study
    • Overgaard K. Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: a dose-response study. Calcif Tissue Int 55 (1994) 82-86
    • (1994) Calcif Tissue Int , vol.55 , pp. 82-86
    • Overgaard, K.1
  • 90
    • 20944438677 scopus 로고    scopus 로고
    • Clinical outcome of salmon calcitonin nasal spray treatment in postmenopausal women after total hip arthroplasty
    • Peichl P., Griesmacher A., Kumpan W., et al. Clinical outcome of salmon calcitonin nasal spray treatment in postmenopausal women after total hip arthroplasty. Gerontology 51 (2005) 242-252
    • (2005) Gerontology , vol.51 , pp. 242-252
    • Peichl, P.1    Griesmacher, A.2    Kumpan, W.3
  • 91
    • 18044364998 scopus 로고    scopus 로고
    • Salmon calcitonin nasal spray treatment for postmenopausal women after hip fracture with total hip arthroplasty
    • Peichl P., Marteau R., Griesmacher A., et al. Salmon calcitonin nasal spray treatment for postmenopausal women after hip fracture with total hip arthroplasty. J Bone Miner Metab 23 (2005) 243-252
    • (2005) J Bone Miner Metab , vol.23 , pp. 243-252
    • Peichl, P.1    Marteau, R.2    Griesmacher, A.3
  • 92
    • 0029559603 scopus 로고
    • Changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty. A 3-year follow-up of 25 knees
    • Petersen M.M., Nielsen P.T., Lauritzen J.B., and Lund B. Changes in bone mineral density of the proximal tibia after uncemented total knee arthroplasty. A 3-year follow-up of 25 knees. Acta Orthop Scand 66 (1995) 513-516
    • (1995) Acta Orthop Scand , vol.66 , pp. 513-516
    • Petersen, M.M.1    Nielsen, P.T.2    Lauritzen, J.B.3    Lund, B.4
  • 93
    • 0031813562 scopus 로고    scopus 로고
    • Problems with the Mennen plate when used for femoral fractures associated with implants. A report of 5 patients
    • Petersen V.S. Problems with the Mennen plate when used for femoral fractures associated with implants. A report of 5 patients. Int Orthop 22 (1998) 169-170
    • (1998) Int Orthop , vol.22 , pp. 169-170
    • Petersen, V.S.1
  • 94
    • 3242810659 scopus 로고    scopus 로고
    • A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium
    • Pi M., and Quarles L.D. A novel cation-sensing mechanism in osteoblasts is a molecular target for strontium. J Bone Miner Res 19 (2004) 862-869
    • (2004) J Bone Miner Res , vol.19 , pp. 862-869
    • Pi, M.1    Quarles, L.D.2
  • 95
    • 0032722149 scopus 로고    scopus 로고
    • Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
    • Plotkin L.I., Weinstein R.S., Parfitt A.M., et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104 (1999) 1363-1374
    • (1999) J Clin Invest , vol.104 , pp. 1363-1374
    • Plotkin, L.I.1    Weinstein, R.S.2    Parfitt, A.M.3
  • 96
    • 33845970601 scopus 로고    scopus 로고
    • Osteoporosis and its management
    • Poole K.E., and Compston J.E. Osteoporosis and its management. BMJ 333 (2006) 1251-1256
    • (2006) BMJ , vol.333 , pp. 1251-1256
    • Poole, K.E.1    Compston, J.E.2
  • 97
    • 0036235943 scopus 로고    scopus 로고
    • Implant design affects markers of bone resorption and formation in total hip replacement
    • Qureshi A.A., Virdi A.S., Didonna M.L., et al. Implant design affects markers of bone resorption and formation in total hip replacement. J Bone Miner Res 17 (2002) 800-807
    • (2002) J Bone Miner Res , vol.17 , pp. 800-807
    • Qureshi, A.A.1    Virdi, A.S.2    Didonna, M.L.3
  • 98
    • 31044432767 scopus 로고    scopus 로고
    • Pathogenesis of osteoporosis: concepts, conflicts, and prospects
    • Raisz L.G. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115 (2005) 3318-3325
    • (2005) J Clin Invest , vol.115 , pp. 3318-3325
    • Raisz, L.G.1
  • 99
    • 21044447888 scopus 로고    scopus 로고
    • Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study
    • Reginster J.Y., Seeman E., De Vernejoul M.C., et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90 (2005) 2816-2822
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 2816-2822
    • Reginster, J.Y.1    Seeman, E.2    De Vernejoul, M.C.3
  • 100
    • 0028949069 scopus 로고
    • Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial
    • Reid I.R., Ames R.W., Evans M.C., et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 98 (1995) 331-335
    • (1995) Am J Med , vol.98 , pp. 331-335
    • Reid, I.R.1    Ames, R.W.2    Evans, M.C.3
  • 101
    • 0034326253 scopus 로고    scopus 로고
    • Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts
    • Reinholz G.G., Getz B., Pederson L., et al. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60 (2000) 6001-6007
    • (2000) Cancer Res , vol.60 , pp. 6001-6007
    • Reinholz, G.G.1    Getz, B.2    Pederson, L.3
  • 102
    • 26044432463 scopus 로고    scopus 로고
    • Indirect reduction and plate fixation, without grafting, for periprosthetic femoral shaft fractures about a stable intramedullary implant
    • Ricci W.M., Bolhofner B.R., Loftus T., et al. Indirect reduction and plate fixation, without grafting, for periprosthetic femoral shaft fractures about a stable intramedullary implant. J Bone Joint Surg Am 87 (2005) 2240-2245
    • (2005) J Bone Joint Surg Am , vol.87 , pp. 2240-2245
    • Ricci, W.M.1    Bolhofner, B.R.2    Loftus, T.3
  • 103
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial
    • Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
    • (2002) JAMA , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3
  • 104
    • 0037406825 scopus 로고    scopus 로고
    • The anabolic effects of parathyroid hormone therapy
    • Rubin M., and Bilezikian J. The anabolic effects of parathyroid hormone therapy. Clin Geriat Med 19 (2002) 415-432
    • (2002) Clin Geriat Med , vol.19 , pp. 415-432
    • Rubin, M.1    Bilezikian, J.2
  • 105
    • 0025368959 scopus 로고
    • Effects of human growth hormone in men over 60 years old
    • Rudman D., Feller A.G., Nagraj H.S., et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 323 (1990) 1-6
    • (1990) N Engl J Med , vol.323 , pp. 1-6
    • Rudman, D.1    Feller, A.G.2    Nagraj, H.S.3
  • 106
    • 0028566599 scopus 로고
    • Effect of tibolone on postmenopausal bone loss
    • Rymer J., Chapman M.G., and Fogelman I. Effect of tibolone on postmenopausal bone loss. Osteoporos Int 4 (1994) 314-319
    • (1994) Osteoporos Int , vol.4 , pp. 314-319
    • Rymer, J.1    Chapman, M.G.2    Fogelman, I.3
  • 107
    • 0034954180 scopus 로고    scopus 로고
    • Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss
    • Rymer J., Robinson J., and Fogelman I. Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss. Osteoporos Int 12 (2001) 478-483
    • (2001) Osteoporos Int , vol.12 , pp. 478-483
    • Rymer, J.1    Robinson, J.2    Fogelman, I.3
  • 108
    • 0036970056 scopus 로고    scopus 로고
    • Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women
    • Rymer J., Robinson J., and Fogelman I. Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women. Climacteric 5 (2002) 390-398
    • (2002) Climacteric , vol.5 , pp. 390-398
    • Rymer, J.1    Robinson, J.2    Fogelman, I.3
  • 109
    • 0031732534 scopus 로고    scopus 로고
    • Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption
    • Sabokbar A., Fujikawa Y., Murray D.W., and Athanasou N.A. Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption. Ann Rheum Dis 57 (1998) 614-618
    • (1998) Ann Rheum Dis , vol.57 , pp. 614-618
    • Sabokbar, A.1    Fujikawa, Y.2    Murray, D.W.3    Athanasou, N.A.4
  • 110
    • 0036721125 scopus 로고    scopus 로고
    • Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH
    • Sato M., Vahle J., Schmidt A., et al. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH. Endocrinology 143 (2002) 3230-3242
    • (2002) Endocrinology , vol.143 , pp. 3230-3242
    • Sato, M.1    Vahle, J.2    Schmidt, A.3
  • 111
    • 0034319201 scopus 로고    scopus 로고
    • Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis
    • Schwarz E.M., Benz E.B., Lu A.P., et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 18 (2000) 849-855
    • (2000) J Orthop Res , vol.18 , pp. 849-855
    • Schwarz, E.M.1    Benz, E.B.2    Lu, A.P.3
  • 112
    • 0033059331 scopus 로고    scopus 로고
    • Is bone density in the distal femur affected by use of cement and by femoral component design in total knee arthroplasty?
    • Seki T., Omori G., Koga Y., et al. Is bone density in the distal femur affected by use of cement and by femoral component design in total knee arthroplasty?. J Orthop Sci 4 (1999) 180-186
    • (1999) J Orthop Sci , vol.4 , pp. 180-186
    • Seki, T.1    Omori, G.2    Koga, Y.3
  • 113
    • 0031280306 scopus 로고    scopus 로고
    • The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model
    • Shanbhag A.S., Hasselman C.T., and Rubash H.E. The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res 344 (1997) 33-43
    • (1997) Clin Orthop Relat Res , vol.344 , pp. 33-43
    • Shanbhag, A.S.1    Hasselman, C.T.2    Rubash, H.E.3
  • 114
    • 33746223260 scopus 로고    scopus 로고
    • Use of bisphosphonates to improve the durability of total joint replacements
    • Shanbhag A.S. Use of bisphosphonates to improve the durability of total joint replacements. J Am Acad Orthop Surg 14 (2006) 215-225
    • (2006) J Am Acad Orthop Surg , vol.14 , pp. 215-225
    • Shanbhag, A.S.1
  • 115
    • 33750341421 scopus 로고    scopus 로고
    • Clinical and radiological outcome of total hip replacement five years after pamidronate therapy. A trial extension
    • Shetty N., Hamer A.J., Stockley I., et al. Clinical and radiological outcome of total hip replacement five years after pamidronate therapy. A trial extension. J Bone Joint Surg Br 88 (2006) 1309-1315
    • (2006) J Bone Joint Surg Br , vol.88 , pp. 1309-1315
    • Shetty, N.1    Hamer, A.J.2    Stockley, I.3
  • 116
    • 27544497563 scopus 로고    scopus 로고
    • Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty
    • Author reply 2590
    • Shetty N.R., Hamer A.J., Stockley I., et al. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. J Bone Joint Surg Am 87 (2005) 2589-2590 Author reply 2590
    • (2005) J Bone Joint Surg Am , vol.87 , pp. 2589-2590
    • Shetty, N.R.1    Hamer, A.J.2    Stockley, I.3
  • 117
    • 0038133361 scopus 로고    scopus 로고
    • Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients
    • Soininvaara T.A., Jurvelin J.S., Miettinen H.J., et al. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients. Calcif Tissue Int 71 (2002) 472-477
    • (2002) Calcif Tissue Int , vol.71 , pp. 472-477
    • Soininvaara, T.A.1    Jurvelin, J.S.2    Miettinen, H.J.3
  • 118
    • 12944326303 scopus 로고    scopus 로고
    • Acute effects of calcitonin nasal spray on serum C-telopeptide of type 1 collagen (CTx) levels in elderly osteopenic women with increased bone turnover
    • Srivastava A.K., Libanati C., Hohmann O., et al. Acute effects of calcitonin nasal spray on serum C-telopeptide of type 1 collagen (CTx) levels in elderly osteopenic women with increased bone turnover. Calcif Tissue Int 75 (2004) 477-481
    • (2004) Calcif Tissue Int , vol.75 , pp. 477-481
    • Srivastava, A.K.1    Libanati, C.2    Hohmann, O.3
  • 119
    • 0030741644 scopus 로고    scopus 로고
    • Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures
    • Sugimoto T., Nishiyama K., Kuribayashi F., and Chihara K. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 12 (1997) 1272-1279
    • (1997) J Bone Miner Res , vol.12 , pp. 1272-1279
    • Sugimoto, T.1    Nishiyama, K.2    Kuribayashi, F.3    Chihara, K.4
  • 120
    • 1942502870 scopus 로고    scopus 로고
    • Tibolone: a unique version of hormone replacement therapy
    • Swegle J.M., and Kelly M.W. Tibolone: a unique version of hormone replacement therapy. Ann Pharmacother 38 (2004) 874-881
    • (2004) Ann Pharmacother , vol.38 , pp. 874-881
    • Swegle, J.M.1    Kelly, M.W.2
  • 121
    • 12244268605 scopus 로고    scopus 로고
    • Dall-Miles plates for periprosthetic femoral fractures. A critical review of 16 cases
    • Tsiridis E., Haddad F.S., and Gie G.A. Dall-Miles plates for periprosthetic femoral fractures. A critical review of 16 cases. Injury 34 (2003) 107-110
    • (2003) Injury , vol.34 , pp. 107-110
    • Tsiridis, E.1    Haddad, F.S.2    Gie, G.A.3
  • 122
    • 12244294451 scopus 로고    scopus 로고
    • Gie GA The management of periprosthetic femoral fractures around hip replacements
    • Tsiridis E., and Haddad F.S. Gie GA The management of periprosthetic femoral fractures around hip replacements. Injury 34 (2003) 95-105
    • (2003) Injury , vol.34 , pp. 95-105
    • Tsiridis, E.1    Haddad, F.S.2
  • 123
    • 0141521803 scopus 로고    scopus 로고
    • Mennen plate fixation for the treatment of periprosthetic femoral fractures
    • Tsiridis E., and Narvani A. Mennen plate fixation for the treatment of periprosthetic femoral fractures. J Bone Joint Surg Am 85 (2003) 1851
    • (2003) J Bone Joint Surg Am , vol.85 , pp. 1851
    • Tsiridis, E.1    Narvani, A.2
  • 124
    • 9144265516 scopus 로고    scopus 로고
    • Impaction femoral allografting and cemented revision for periprosthetic femoral fractures
    • Tsiridis E., Narvani A.A., Haddad F.S., et al. Impaction femoral allografting and cemented revision for periprosthetic femoral fractures. J Bone Joint Surg Br 86 (2004) 1124-1132
    • (2004) J Bone Joint Surg Br , vol.86 , pp. 1124-1132
    • Tsiridis, E.1    Narvani, A.A.2    Haddad, F.S.3
  • 125
    • 1642377164 scopus 로고    scopus 로고
    • Dall-Miles plates for periprosthetic femoral fractures a critical review of 16 cases
    • Tsiridis E. Dall-Miles plates for periprosthetic femoral fractures a critical review of 16 cases. Injury 35 (2004) 440-441
    • (2004) Injury , vol.35 , pp. 440-441
    • Tsiridis, E.1
  • 126
    • 24144445074 scopus 로고    scopus 로고
    • Gie GA dynamic compression plates for Vancouver type B periprosthetic femoral fractures: a 3-year follow-up of 18 cases
    • Tsiridis E., Narvani A.A., and Timperley J.A. Gie GA dynamic compression plates for Vancouver type B periprosthetic femoral fractures: a 3-year follow-up of 18 cases. Acta Orthop 76 (2005) 531-537
    • (2005) Acta Orthop , vol.76 , pp. 531-537
    • Tsiridis, E.1    Narvani, A.A.2    Timperley, J.A.3
  • 127
    • 0030278360 scopus 로고    scopus 로고
    • Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
    • Tucci J.R., Tonino R.P., Emkey R.D., et al. Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101 (1996) 488-501
    • (1996) Am J Med , vol.101 , pp. 488-501
    • Tucci, J.R.1    Tonino, R.P.2    Emkey, R.D.3
  • 128
    • 0031907272 scopus 로고    scopus 로고
    • Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with oestrogen?
    • Tuppurainen M.T., Komulainen M., Kroger H., et al. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with oestrogen?. Osteoporos Int 8 (1998) 32-38
    • (1998) Osteoporos Int , vol.8 , pp. 32-38
    • Tuppurainen, M.T.1    Komulainen, M.2    Kroger, H.3
  • 129
    • 0036704231 scopus 로고    scopus 로고
    • Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis
    • Ulrich-Vinther M., Carmody E.E., Goater J.J., et al. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 84 (2002) 1405-1412
    • (2002) J Bone Joint Surg Am , vol.84 , pp. 1405-1412
    • Ulrich-Vinther, M.1    Carmody, E.E.2    Goater, J.J.3
  • 130
    • 0034997620 scopus 로고    scopus 로고
    • Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry-a 3-year follow-up study
    • Venesmaa P.K., Kroger H.P., Miettinen H.J., et al. Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry-a 3-year follow-up study. J Bone Miner Res 16 (2001) 1056-1061
    • (2001) J Bone Miner Res , vol.16 , pp. 1056-1061
    • Venesmaa, P.K.1    Kroger, H.P.2    Miettinen, H.J.3
  • 131
    • 0034773441 scopus 로고    scopus 로고
    • Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study
    • Venesmaa P.K., Kroger H.P., Miettinen H.J., et al. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study. J Bone Miner Res 16 (2001) 2126-2131
    • (2001) J Bone Miner Res , vol.16 , pp. 2126-2131
    • Venesmaa, P.K.1    Kroger, H.P.2    Miettinen, H.J.3
  • 132
    • 0037329878 scopus 로고    scopus 로고
    • Periprosthetic bone loss after cemented total hip arthroplasty: a prospective 5-year dual energy radiographic absorptiometry study of 15 patients
    • Venesmaa P.K., Kroger H.P., Jurvelin J.S., et al. Periprosthetic bone loss after cemented total hip arthroplasty: a prospective 5-year dual energy radiographic absorptiometry study of 15 patients. Acta Orthopaed Scand 74 (2003) 31-36
    • (2003) Acta Orthopaed Scand , vol.74 , pp. 31-36
    • Venesmaa, P.K.1    Kroger, H.P.2    Jurvelin, J.S.3
  • 133
    • 23244462780 scopus 로고    scopus 로고
    • Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells
    • von Knoch F., Jaquiery C., Kowalsky M., et al. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 26 (2005) 6941-6949
    • (2005) Biomaterials , vol.26 , pp. 6941-6949
    • von Knoch, F.1    Jaquiery, C.2    Kowalsky, M.3
  • 134
    • 26844543513 scopus 로고    scopus 로고
    • Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin
    • von Knoch F., Heckelei A., Wedemeyer C., et al. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. J Biomed Mater Res A 75 (2005) 288-294
    • (2005) J Biomed Mater Res A , vol.75 , pp. 288-294
    • von Knoch, F.1    Heckelei, A.2    Wedemeyer, C.3
  • 135
    • 0242659162 scopus 로고    scopus 로고
    • The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty
    • Wang C.J., Wang J.W., Weng L.H., et al. The effect of alendronate on bone mineral density in the distal part of the femur and proximal part of the tibia after total knee arthroplasty. J Bone Joint Surg Am 85 (2003) 2121-2126
    • (2003) J Bone Joint Surg Am , vol.85 , pp. 2121-2126
    • Wang, C.J.1    Wang, J.W.2    Weng, L.H.3
  • 136
    • 31844455472 scopus 로고    scopus 로고
    • Three-year changes in bone mineral density around the knee after a six-month course of oral alendronate following total knee arthroplasty. A prospective, randomized study
    • Wang C.J., Wang J.W., Ko J.Y., et al. Three-year changes in bone mineral density around the knee after a six-month course of oral alendronate following total knee arthroplasty. A prospective, randomized study. J Bone Joint Surg Am 88 (2006) 267-272
    • (2006) J Bone Joint Surg Am , vol.88 , pp. 267-272
    • Wang, C.J.1    Wang, J.W.2    Ko, J.Y.3
  • 137
    • 0035101830 scopus 로고    scopus 로고
    • Effect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial
    • Wilkinson J.M., Stockley I., Peel N.F., et al. Effect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial. J Bone Miner Res 16 (2001) 556-564
    • (2001) J Bone Miner Res , vol.16 , pp. 556-564
    • Wilkinson, J.M.1    Stockley, I.2    Peel, N.F.3
  • 138
    • 0242578072 scopus 로고    scopus 로고
    • Effect of pamidronate on excretion of pyridinium crosslinks of collagen after total hip arthroplasty
    • Wilkinson J.M., Jackson B., and Eastell R. Effect of pamidronate on excretion of pyridinium crosslinks of collagen after total hip arthroplasty. Calcif Tissue Int 73 (2003) 326-331
    • (2003) Calcif Tissue Int , vol.73 , pp. 326-331
    • Wilkinson, J.M.1    Jackson, B.2    Eastell, R.3
  • 139
    • 0038207088 scopus 로고    scopus 로고
    • Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplasty
    • Wilkinson J.M., Hamer A.J., Rogers A., et al. Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplasty. J Orthop Res 21 (2003) 691-696
    • (2003) J Orthop Res , vol.21 , pp. 691-696
    • Wilkinson, J.M.1    Hamer, A.J.2    Rogers, A.3
  • 140
    • 11044233501 scopus 로고    scopus 로고
    • Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: a randomized trial
    • Wilkinson J.M., Eagleton A.C., Stockley I., et al. Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: a randomized trial. J Orthop Res 23 (2005) 1-8
    • (2005) J Orthop Res , vol.23 , pp. 1-8
    • Wilkinson, J.M.1    Eagleton, A.C.2    Stockley, I.3
  • 141
    • 0036746089 scopus 로고    scopus 로고
    • Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model
    • Yang S.Y., Mayton L., Wu B., et al. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. Arthritis Rheum 46 (2002) 2514-2523
    • (2002) Arthritis Rheum , vol.46 , pp. 2514-2523
    • Yang, S.Y.1    Mayton, L.2    Wu, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.